Download PDF
Journal of Pediatric Epilepsy 2018; 07(02): 076-080
DOI: 10.1055/s-0038-1668585
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Epilepsy Surgery in Antibody-Associated Autoimmune Encephalitis and Epilepsies: Review of Literature

Aimee F. Luat
1   Carman and Ann Adams Departments of Pediatrics and Neurology, Children's Hospital of Michigan, Detroit Medical Center Wayne State University School of Medicine, Detroit, Michigan, United States
› Author Affiliations
Further Information

Publication History

02 June 2018

20 June 2018

Publication Date:
03 September 2018 (online)

    Permissions and Reprints

Abstract

There is lack of studies that explore the role of epilepsy surgery in the treatment of drug-refractory antibody-associated autoimmune encephalitis and epilepsies. Some case reports and series suggest that surgical treatment may still be an option, but compared with other etiologies, its surgical outcome seems to be less favorable. The following review summarizes the existing experience on the surgical treatment of drug-refractory seizures associated with antibody-associated autoimmune encephalitis and epilepsies.

Keywords

autoantibody - encephalitis - surgery
 

  • References

  • 1 Iffland II PH, Carvalho-Tavares J, Trigunaite A. , et al. Intracellular and circulating neuronal antinuclear antibodies in human epilepsy. Neurobiol Dis 2013; 59: 206-219
    CrossrefPubMedGoogle Scholar
  • 2 Dalmau J, Tüzün E, Wu HY. , et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61 (01) 25-36
    CrossrefPubMedGoogle Scholar
  • 3 Irani SR, Michell AW, Lang B. , et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011; 69 (05) 892-900
    CrossrefPubMedGoogle Scholar
  • 4 Lancaster E, Lai M, Peng X. , et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010; 9 (01) 67-76
    CrossrefPubMedGoogle Scholar
  • 5 Lai M, Hughes EG, Peng X. , et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009; 65 (04) 424-434
    CrossrefPubMedGoogle Scholar
  • 6 Suleiman J, Dale RC. The recognition and treatment of autoimmune epilepsy in children. Dev Med Child Neurol 2015; 57 (05) 431-440
    CrossrefPubMedGoogle Scholar
  • 7 Dubey D, Alqallaf A, Hays R. , et al. Neurological autoantibody prevalence in epilepsy of unknown etiology. JAMA Neurol 2017; 74 (04) 397-402
    CrossrefPubMedGoogle Scholar
  • 8 Scheffer IE, Berkovic S, Capovilla G. , et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58 (04) 512-521
    CrossrefPubMedGoogle Scholar
  • 9 Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011; 77 (02) 179-189
    CrossrefPubMedGoogle Scholar
  • 10 Bien CG, Bauer J. Autoimmune epilepsies. Neurotherapeutics 2014; 11 (02) 311-318
    CrossrefPubMedGoogle Scholar
  • 11 Dalmau J, Gleichman AJ, Hughes EG. , et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7 (12) 1091-1098
    CrossrefPubMedGoogle Scholar
  • 12 Bastiaansen AEM, van Sonderen A, Titulaer MJ. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies). Curr Opin Neurol 2017; 30 (03) 302-309
    CrossrefPubMedGoogle Scholar
  • 13 Herranz-Pérez V, Olucha-Bordonau FE, Morante-Redolat JM, Pérez-Tur J. Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain. Brain Res 2010; 1307: 177-194
    CrossrefPubMedGoogle Scholar
  • 14 Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 2006; 313 (5794): 1792-1795
    CrossrefPubMedGoogle Scholar
  • 15 Ohkawa T, Fukata Y, Yamasaki M. , et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013; 33 (46) 18161-18174
    CrossrefPubMedGoogle Scholar
  • 16 Britton J. Autoimmune epilepsy. Handb Clin Neurol 2016; 133: 219-245
    PubMedGoogle Scholar
  • 17 Byun JI, Lee ST, Jung KH. , et al. Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: a prospective observational registry study. PLoS One 2016; 11 (01) e0146455
    CrossrefPubMedGoogle Scholar
  • 18 Urbach H, Soeder BM, Jeub M, Klockgether T, Meyer B, Bien CG. Serial MRI of limbic encephalitis. Neuroradiology 2006; 48 (06) 380-386
    CrossrefPubMedGoogle Scholar
  • 19 Kotsenas AL, Watson RE, Pittock SJ. , et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. Am J Neuroradiol 2014; 35 (01) 84-89
    CrossrefPubMedGoogle Scholar
  • 20 Carreño M, Bien CG, Asadi-Pooya AA. , et al. Epilepsy surgery in drug resistant temporal lobe epilepsy associated with neuronal antibodies. Epilepsy Res 2017; 129: 101-105
    CrossrefPubMedGoogle Scholar
  • 21 Gagnon MM, Savard M, Mourabit Amari K. Refractory status epilepticus and autoimmune encephalitis with GABAAR and GAD65 antibodies: a case report. Seizure 2016; 37: 25-27
    CrossrefPubMedGoogle Scholar
  • 22 Petit-Pedrol M, Armangue T, Peng X. , et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014; 13 (03) 276-286
    CrossrefPubMedGoogle Scholar
  • 23 Kirkpatrick MP, Clarke CD, Sonmezturk HH, Abou-Khalil B. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 2011; 20 (02) 392-394
    CrossrefPubMedGoogle Scholar
  • 24 Johnson N, Henry C, Fessler AJ, Dalmau J. Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 2010; 75 (16) 1480-1482
    CrossrefPubMedGoogle Scholar
  • 25 Ilyas M, Sivaswamy L, Asano E, Sood S, Zidan M, Chugani H. Seizure control following palliative resective surgery for intractable epilepsy-a pilot study. Pediatr Neurol 2014; 51 (03) 330-335
    CrossrefPubMedGoogle Scholar
  • 26 Kumar A, Chugani HT, Luat A, Asano E, Sood S. Epilepsy surgery in a case of encephalitis: use of 11C-PK11195 positron emission tomography. Pediatr Neurol 2008; 38 (06) 439-442
    CrossrefPubMedGoogle Scholar
  • 27 Barros P, Brito H, Ferreira PC. , et al. Resective surgery in the treatment of super-refractory partial status epilepticus secondary to NMDAR antibody encephalitis. Eur J Paediatr Neurol 2014; 18 (03) 449-452
    CrossrefPubMedGoogle Scholar
  • 28 Muehlebner A, Groeppel G, Pahs G. , et al. Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis. Epilepsy Res 2010; 90 (03) 295-299
    CrossrefPubMedGoogle Scholar
  • 29 Sato Y, Numata-Uematsu Y, Uematsu M. , et al. Acute encephalitis with refractory, repetitive partial seizures: Pathological findings and a new therapeutic approach using tacrolimus. Brain Dev 2016; 38 (08) 772-776
    CrossrefPubMedGoogle Scholar
  • 30 Almeida V, Pimentel J, Campos A. , et al. Surgical control of limbic encephalitis associated with LGI1 antibodies. Epileptic Disord 2012; 14 (03) 345-348
    PubMedGoogle Scholar
  • 31 Weimer T, Boling W, Pryputniewicz D, Palade A. Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis. J Neurosurg 2008; 109 (04) 742-745
    CrossrefPubMedGoogle Scholar
  • 32 Bick SK, Izzy S, Rubin DB, Zafar SF, Rosenthal ES, Eskandar EN. Anterior temporal lobectomy for refractory status epilepticus in herpes simplex encephalitis. Neurocrit Care 2016; 25 (03) 458-463
    CrossrefPubMedGoogle Scholar
  • 33 Malter MP, Frisch C, Zeitler H. , et al. Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure 2015; 30: 57-63
    CrossrefPubMedGoogle Scholar
  • 34 Quek AM, Britton JW, McKeon A. , et al. Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 2012; 69 (05) 582-593
    CrossrefPubMedGoogle Scholar
  • 35 Glover RL, DeNiro LV, Lasala PA, Weidenheim KM, Graber JJ, Boro A. ILAE type 3 hippocampal sclerosis in patients with anti-GAD-related epilepsy. Neurol Neuroimmunol Neuroinflamm 2015; 2 (04) e122
    CrossrefPubMedGoogle Scholar
  • 36 Vanli-Yavuz EN, Erdag E, Tuzun E. , et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry 2016; 87 (07) 684-692
    CrossrefPubMedGoogle Scholar
  • 37 Kerling F, Blümcke I, Stefan H. Pitfalls in diagnosing limbic encephalitis - a case report. Acta Neurol Scand 2008; 118 (05) 339-342
    CrossrefPubMedGoogle Scholar
  • 38 Yamazoe T, Okanishi T, Yamamoto A. , et al. New-onset refractory status epilepticus treated with vagus nerve stimulation: a case report. Seizure 2017; 47: 1-4
    CrossrefPubMedGoogle Scholar
  • 39 Alsaadi T, Shakra M, Turkawi L, Hamid J. VNS terminating refractory nonconvulsive SE secondary to anti-NMDA encephalitis: a case report. Epilepsy Behav Case Rep 2015; 3: 39-42
    PubMedGoogle Scholar
  • 40 Mathon B, Bédos Ulvin L, Adam C. , et al. Surgical treatment for mesial temporal lobe epilepsy associated with hippocampal sclerosis. Rev Neurol (Paris) 2015; 171 (03) 315-325
    CrossrefPubMedGoogle Scholar
  • 41 Patwardhan RV, Dellabadia Jr J, Rashidi M, Grier L, Nanda A. Control of refractory status epilepticus precipitated by anticonvulsant withdrawal using left vagal nerve stimulation: a case report. Surg Neurol 2005; 64 (02) 170-173
    CrossrefPubMedGoogle Scholar
  • 42 O'Neill BR, Valeriano J, Synowiec A, Thielmann D, Lane C, Wilberger J. Refractory status epilepticus treated with vagal nerve stimulation: case report. Neurosurgery 2011; 69 (05) E1172-E1175
    CrossrefPubMedGoogle Scholar
  • 43 Sierra-Marcos A, Maestro I, Rodríguez-Osorio X. , et al. Successful outcome of episodes of status epilepticus after vagus nerve stimulation: a multicenter study. Eur J Neurol 2012; 19 (09) 1219-1223
    CrossrefPubMedGoogle Scholar
  • 44 De Herdt V, Waterschoot L, Vonck K. , et al. Vagus nerve stimulation for refractory status epilepticus. Eur J Paediatr Neurol 2009; 13 (03) 286-289
    CrossrefPubMedGoogle Scholar
  • 45 Winston KR, Levisohn P, Miller BR, Freeman J. Vagal nerve stimulation for status epilepticus. Pediatr Neurosurg 2001; 34 (04) 190-192
    CrossrefPubMedGoogle Scholar
  • 46 De Herdt V, Bogaert S, Bracke KR. , et al. Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 2009; 214 (1–2): 104-108
    CrossrefPubMedGoogle Scholar
  • 47 Aalbers MW, Klinkenberg S, Rijkers K. , et al. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in children with refractory epilepsy: an exploratory study. Neuroimmunomodulation 2012; 19 (06) 352-358
    CrossrefPubMedGoogle Scholar
  • 48 Bhatia S, Schmitt SE. Treating immune-related epilepsy. Curr Neurol Neurosci Rep 2018; 18 (03) 10
    CrossrefPubMedGoogle Scholar